Welcome to the Box Office Report where America and Tom Cruise both need a tissue.
1. The Fault in Our Stars (Fox): $48.2 million in 3,193 theaters.
A romantic tear-jerker about two teenage cancer patients who fall in love. An audience that was 82 percent female. A marketing masterstroke mixed with some good acting, some very strong critics reviews, some raving audience feedback. That's how you get to number one on a $12 million budget. Check out our interview with writer John Green for some real insights on the project.
2. Maleficent (Buena Vista): $33.5 million in 3,948 theaters.
Maleficent took a tumble in its sophmore frame, but managed to hold onto the number two spot despite some less-than-encouraging reviews. Nevertheless, the rule should hold: Put Angelina Jolie in the spotlight, add some special effects, and that'll probably be enough to carry you through.
3. Edge of Tomorrow (Warner Brothers): $29.1 million in 3,490 theaters.
Poor Tom Cruise. Despite some pretty rave reviews, Edge of Tomorrow (as we predicted) is proving to be a movie beloved by a limited cinema-going audience. While the sci-fi flick performed well overseas, bringing it within striking distance of its $180 million budget, it failed to garner hype here. Maybe some strong word-of-mouth will keep this one on the list for a few more weeks.
4. X-Men: Days of Future Past (Fox): $14.7 million in 3,639 theaters.
Yes, this movie is making a boatload of money overseas, but in just three weeks, the latest in this Marvel franchise has gone from about $91 million to just under $15 million at home. Given the strong reviews, this seems like a symptom of franchise fatigue.
5. A Million Ways to Die in the West (Universal): $7.2 million in 3,160 theaters.
Critics hated it. Audiences luke-warmed it. And after one meek Week One opening, Seth MacFarlane's Western comedy homage stumbled by half to the bottom of the top. This is already looking like a forgettable blip in MacFarlane's career, right next to his turn as Oscar host.
This article is from the archive of our partner The Wire.
We want to hear what you think about this article. Submit a letter to the editor or write to firstname.lastname@example.org.